The virulence factors of Bordetella pertussis: A matter of control

FEMS Microbiology Reviews

Volumn 25, Issue 3, 2001, Pages 309-333

  Smith, Adam M ^a   Guzmán, Carlos A ^b   Walker, Mark J ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Adenylate cyclase; Bordetella; bvg; Filamentous hemagglutinin; Fimbria; Pertactin; Pertussis toxin; Virulence factor expression

Indexed keywords

ADENYLATE CYCLASE; ADHESIN; DERMONECROTIC TOXIN; HEMAGGLUTININ; HEMOLYSIN; LIPOPOLYSACCHARIDE; PERTACTIN; PERTUSSIS TOXIN; PROTEIN SUBUNIT; RNA POLYMERASE; TRACHEAL COLONIZATION FACTOR; TRACHEAL CYTOTOXIN; UNCLASSIFIED DRUG; UREASE; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BIOGENESIS; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; CILIATED EPITHELIUM; DNA SEQUENCE; FIMBRIA; GENE CLUSTER; GENE EXPRESSION; GENETIC REGULATION; IMMUNE RESPONSE; NONHUMAN; OPERON; PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; REVIEW; TRANSCRIPTION REGULATION; UPPER RESPIRATORY TRACT;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; BORDETELLA PERTUSSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PERTUSSIS VACCINE; VIRULENCE; WHOOPING COUGH;

EID: 0035021498     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(01)00056-0     Document Type: Review

References (262)

1. World Health Organization (1999) The World Health Report, 1999: Making a Difference. World Health Organization, Geneva.
2. Bordet J., Gengou O. Le microbe de la coqueluche. Ann. Inst. Pasteur (Paris). 20:1906;731-741.
3. Lopez M.M. El genero Bordetella. Microbiol. Esp. 5:1952;177-183.
4. van der Zee A., Mooi F., van Embden J., Musser J. Molecular evolution and host adaptation of Bordetella spp. - phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J. Bacteriol. 179:1997;6609-6617.
5. Arico B., Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J. Bacteriol. 169:1987;2847-2853.
6. Cullinane L.C., Alley M.R., Marshall R.B., Manktelow B.W. Bordetella parapertussis from lambs. NZ Vet. J. 35:1987;175.
7. Goodnow R.A. Biology of Bordetella bronchiseptica. Microbiol. Rev. 44:1980;722-738.
8. Switzer W.P. Studies on infectious atrophic rhinitis. V. Concept that several agents may cause turbinate atrophy. Am. J. Vet. Res. 17:1956;478-484.
9. Thompson H., McCandlish I.A., Wright N.G. Experimental respiratory disease in dogs due to Bordetella bronchiseptica. Res. Vet. Sci. 20:1976;16-23.
10. Gross R., Arico B., Rappuoli R. Genetics of pertussis toxin. Mol. Microbiol. 3:1989;119-124.
11. Kersters K., Hinz K.-H., Hertle A., Segers P., Lievens A., Siegmann O., De Ley J. Bordetella avium sp. nov., isolated from the respiratory tracts of turkeys and other birds. Int. J. Syst. Bacteriol. 34:1984;56-70.
12. Cookson B.T., Vandamme P., Carlson L.C., Larson A.M., Sheffield J.V.L., Kersters K., Spach D.H. Bacteremia caused by a novel Bordetella species, B. hinzii. J. Clin. Microbiol. 32:1994;2569-2571.
13. Weyant R.S., Hollis D.G., Weaver R.E., Amin M.F.M., Steigerwalt A.G., Oconnor S.P., Whitney A.M., Daneshvar M.I., Moss C.W., Brenner D.J. Bordetella holmesii sp. nov., a new Gram-negative species associated with septicemia. J. Clin. Microbiol. 33:1995;1-7.
14. van Damme P., Heyndrickx M., Vancanneyt M., Hoste B., Devos P., Falsen E., Kersters K., Hinz K.H. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int. J. Syst. Bacteriol. 46:1996;849-858.
15. van Damme P., Hommez J., Vancanneyt M., Monsieurs M., Hoste B., Cookson B., Wirsing von Konig C.H., Kersters K., Blackall P.J. Bordetella hinzii sp. nov., isolated from poultry and humans. Int. J. Syst. Bacteriol. 45:1995;37-45.
16. Leslie P.H., Gardner A.D. The phases of Haemophilus pertussis. J. Hyg. 31:1931;423-434.
17. Lacey B.W. Antigenic modulation of Bordetella pertussis. J. Hyg. 58:1960;57-93.
18. Cotter P.A., Miller J.F. A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of bvg-regulated antigens. Mol. Microbiol. 24:1997;671-685.
19. Melton A.R., Weiss A.A. Characterization of environmental regulators of Bordetella pertussis. Infect. Immun. 61:1993;807-815.
20. Weiss A.A., Falkow S. Genetic analysis of phase change in Bordetella pertussis. Infect. Immun. 43:1984;263-269.
21. Parkinson J.S., Kofoid E.C. Communication modules in bacterial signalling proteins. Annu. Rev. Genet. 26:1992;71-112.
22. Chang C., Kwok S.F., Bleecker A.B., Meyerowitz E.M. Arabidopsis ethylene-response gene ETR1: similarity of product of two-component regulators. Science. 262:1993;539-544.
23. Choi S.H., Greenberg E.P. The C-terminal region of the Vibrio fischeri LuxR protein contains an inducer-independent lux gene activating domain. Proc. Natl. Acad. Sci. USA. 88:1991;11115-11119.
24. Ota I.M., Varshavsky A. A yeast protein similar to bacterial two-component regulators. Science. 262:1993;566-569.
25. Arico B., Miller J.F., Roy C., Stibitz S., Monack D., Falkow S., Gross R., Rappuoli R. Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc. Natl. Acad. Sci. USA. 86:1989;6671-6675.
26. Coote J.G. Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis. J. Gen. Microbiol. 137:1991;2493-2503.
27. Merkel T.J., Barros C., Stibitz S. Characterisation of the bvgR locus of Bordetella pertussis. J. Bacteriol. 180:1998;1682-1690.
28. Roy C.R., Miller J.F., Falkow S. Autogenous regulation of the Bordetella pertussis bvgABC operon. Proc. Natl. Acad. Sci. USA. 87:1990;3763-3767.
29. Scarlato V., Prugnola A., Arico B., Rappuoli R. Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis. Proc. Natl. Acad. Sci. USA. 87:1990;6753-6757.
30. Steffen P., Goyard S., Ullmann A. Phosphorylated BvgA is sufficient for transcriptional activation of virulence-regulated genes in Bordetella pertussis. EMBO J. 15:1996;102-109.
31. Boucher P.E., Murakami K., Ishihama A., Stibitz S. Nature of DNA binding and RNA polymerase interaction of the Bordetella pertussis BvgA transcriptional activator at the fha promoter. J. Bacteriol. 179:1997;1755-1763.
32. Stibitz S., Yang M.S. Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J. Bacteriol. 173:1991;4288-4296.
33. Boucher P.E., Menozzi F.D., Locht C. The modular architecture of bacterial response regulators. Insights into the activation mechanism of the BvgA transactivator of Bordetella pertussis. J. Mol. Biol. 241:1994;363-377.
34. Kahn D., Ditta G. Modular structure of FixJ: homology of the transcriptional activator domain with the -35 binding domain of sigma factors. Mol. Microbiol. 5:1991;987-997.
35. Choi S.H., Greenberg E.P. Genetic dissection of DNA binding and luminescence gene activation by the Vibrio fischeri LuxR protein. J. Bacteriol. 174:1992;4064-4069.
36. Helmann J.D., Chamberlin M.J. Structure and function of bacterial sigma factors. Annu. Rev. Biochem. 57:1988;839-872.
37. Roy C.R., Miller J.F., Falkow S. The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J. Bacteriol. 171:1989;6338-6344.
38. Roy C.R., Falkow S. Identification of Bordetella pertussis regulatory sequences required for transcriptional activation of the fhaB gene and autoregulation of the bvgAS operon. J. Bacteriol. 173:1991;2385-2392.
39. Marques R.R., Carbonetti N.H. Genetic analysis of pertussis toxin promoter activation in Bordetella pertussis. Mol. Microbiol. 24:1997;1215-1224.
40. Zu T., Manetti R., Rappuoli R., Scarlato V. Differential binding of BvgA to two classes of virulence genes of Bordetella pertussis directs promoter selectivity by RNA polymerase. Mol. Microbiol. 21:1996;557-565.
41. Boucher P.E., Stibitz S. Synergistic binding of RNA polymerase and BvgA phosphate to the pertussis toxin promoter of Bordetella pertussis. J. Bacteriol. 177:1995;6486-6491.
42. Karimova G., Bellalou J., Ullmann A. Phosphorylation-dependent binding of BvgA to the upstream region of the cyaA gene of Bordetella pertussis. Mol. Microbiol. 20:1996;489-496.
43. Uhl M.A., Miller J.F. Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc. Natl. Acad. Sci. USA. 91:1994;1163-1167.
44. Beier D., Schwarz B., Fuchs T.M., Gross R. In vivo characterization of the unorthodox BvgS two-component sensor protein of Bordetella pertussis. J. Mol. Biol. 248:1995;596-610.
45. Manetti R., Arico B., Rappuoli R., Scarlato V. Mutations in the linker region of BvgS abolish response to environmental signals for the regulation of the virulence factors in Bordetella pertussis. Gene. 150:1994;123-127.
46. Uhl M.A., Miller J.F. Central role of the BvgS receiver as a phosphorylated intermediate in a complex two-component phosphorelay. J. Biol. Chem. 271:1996;33176-33180.
47. Uhl M.A., Miller J.F. A new type of phosphodonor in two-component signal transduction systems: the Bordetella pertussis BvgAS phosphorelay. EMBO J. 15:1996;1028-1036.
48. Merkel T.J., Stibitz S. Identification of a locus required for the regulation of bvg-repressed genes in Bordetella pertussis. J. Bacteriol. 177:1995;2727-2736.
49. Beattie D.T., Knapp S., Mekalanos J.J. Evidence that modulation requires sequences downstream of the promoters of two vir-repressed genes of Bordetella pertussis. J. Bacteriol. 172:1990;6997-7004.
50. Beattie D.T., Mahan M.J., Mekalanos J.J. Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis. J. Bacteriol. 175:1993;519-527.
51. Merkel T.J., Stibitz S., Keith J.M., Leef M., Shahin R. Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis. Infect. Immun. 66:1998;4367-4373.
52. Busby S., Ebright R.H. Promoter structure, promoter recognition, and transcription activation in prokaryotes. Cell. 79:1994;743-746.
53. Ishihama A. Role of RNA polymerase α subunit in transcription activation. Mol. Microbiol. 6:1992;3283-3288.
54. Ishihama A. Protein-protein communication within the transcription apparatus. J. Bacteriol. 175:1993;2483-2489.
55. Carbonetti N.H., Fuchs T.M., Patamawenu A.A., Irish T.J., Deppisch H., Gross R. Effect of mutations causing overexpression of RNA polymerase alpha subunit on regulation of virulence factors in Bordetella pertussis. J. Bacteriol. 176:1994;7267-7273.
56. Steffen P., Goyard S., Ullmann A. The Bordetella pertussis sigma subunit of RNA polymerase confers enhanced expression of fha in Escherichia coli. Mol. Microbiol. 23:1997;945-954.
57. Webber C.A., Kadner R.J. Action of receiver and activator modules of UhpA in transcriptional control of the Escherichia coli sugar phosphate transport system. Mol. Microbiol. 15:1995;883-893.
58. Stibitz S. Mutations affecting the alpha subunit of Bordetella pertussis RNA polymerase suppress growth inhibition conferred by short C-terminal deletions of the response regulator BvgA. J. Bacteriol. 180:1998;2484-2492.
59. 4 modulation. J. Bacteriol. 173:1991;7401-7404.
60. Scarlato V., Arico B., Prugnola A., Rappuoli R. Sequential activation and environmental regulation of virulence genes in Bordetella pertussis. EMBO J. 10:1991;3971-3975.
61. Stibitz S. Mutations in the bvgA gene of Bordetella pertussis that differentially affect regulation of virulence determinants. J. Bacteriol. 176:1994;5615-5621.
62. Karimova G., Ullmann A. Characterisation of DNA binding sites for the BvgA protein of Bordetella pertussis. J. Bacteriol. 179:1997;3790-3792.
63. Akerley B.J., Monack D.M., Falkow S., Miller J.F. The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J. Bacteriol. 174:1992;980-990.
64. Chhatwal G.S., Walker M.J., Yan H.R., Timmis K.N., Guzman C.A. Temperature dependent expression of an acid phosphatase by Bordetella bronchiseptica-role in intracellular survival. Microb. Pathogen. 22:1997;257-264.
65. Giardina P.C., Foster L.A., Musser J.M., Akerley B.J., Miller J.F., Dyer D.W. Bvg repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage. J. Bacteriol. 177:1995;6058-6063.
66. McMillan D.J., Shojaei M., Chhatwal G.S., Guzmán C.A., Walker M.J. Molecular analysis of the bvg-repressed urease of Bordetella bronchiseptica. Microb. Pathogen. 21:1996;379-394.
67. Tuomanen E., Towbin H., Rosenfelder G., Braun D., Larson G., Hansson G.C., Hill R. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J. Exp. Med. 168:1988;267-277.
68. Jungnitz H., West N.P., Walker M.J., Chhatwal G.S., Guzman C.A. A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infect. Immun. 66:1998;4640-4650.
69. Miller J.F., Roy C.R., Falkow S. Analysis of Bordetella pertussis virulence gene regulation by use of transcriptional fusions in Escherichia coli. J. Bacteriol. 171:1989;6345-6348.
70. Stibitz S., Weiss A.A., Falkow S. Genetic analysis of a region of the Bordetella pertussis chromosome encoding filamentous hemagglutinin and the pleiotropic regulatory locus vir. J. Bacteriol. 170:1988;2904-2913.
71. Goyard S., Ullmann A. Analysis of Bordetella pertussis cya operon regulation by use of cya-lac fusions. FEMS Microbiol. Lett. 61:1991;251-256.
72. Scarlato V., Arico B., Rappuoli R. DNA topology affects transcriptional regulation of the pertussis toxin gene of Bordetella pertussis in Escherichia coli and in vitro. J. Bacteriol. 175:1993;4764-4771.
73. DeShazer D., Wood G.E., Friedman R.L. Identification of a Bordetella pertussis regulatory factor required for transcription of the pertussis toxin operon in Escherichia coli. J. Bacteriol. 177:1995;3801-3807.
74. Uhl M.A., Miller J.F. BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli. J. Bacteriol. 177:1995;6477-6485.
75. Gross M.K., Au D.C., Smith A.L., Storm D.R. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc. Natl. Acad. Sci. USA. 89:1992;4898-4902.
76. Mooi F.R., Jansen W.H., Brunings H., Gielen H., van der Heide H.G., Walvoort H.C., Guinee P.A. Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae. Microb. Pathogen. 12:1992;127-135.
77. Weiss A.A., Hewlett E.L., Myers G.A., Falkow S. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis. 150:1984;219-222.
78. Weiss A.A., Goodwin M.S. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun. 57:1989;3757-3764.
79. Tuomanen E. Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infect. Immun. 54:1986;905-908.
80. Arai H., Sato Y. Separation and characterisation of two distinct haemagglutinins contained in purified leukocytosis promoting factor from Bordetella pertussis. Biochim. Biophys. Acta. 444:1976;765-782.
81. Makhov A.M., Hannah J.H., Brennan M.J., Trus B.L., Kocsis E., Conway J.F., Wingfield P.T., Simon M.N., Steven A.C. Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns. J. Mol. Biol. 241:1994;110-124.
82. Delisse-Gathoye A., Locht C., Jacob F., Raaschou-Nielsen M., Heron I., Ruelle J.L., de Wilde M., Cabezon T. Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect. Immun. 58:1990;2895-2905.
83. Domenighini M., Relman D., Capiau C., Falkow S., Prugnola A., Scarlato V., Rappuoli R. Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor. Mol. Microbiol. 4:1990;787-800.
84. Locht C., Bertin P., Menozzi F.D., Renauld G. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol. Microbiol. 9:1993;653-660.
85. Tuomanen E., Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J. Infect. Dis. 152:1985;118-125.
86. Relman D.A., Domenighini M., Tuomanen E., Rappuoli R., Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc. Natl. Acad. Sci. USA. 86:1989;2637-2641.
87. Prasad S.M., Yin Y., Rodzinski E., Tuomanen E.I., Masure H.R. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect. Immun. 61:1993;2780-2785.
88. Liu D.-F., Phillips E., Wizemann T.M., Siegel M.M., Tabei K., Cowell J.L., Tuomanen E. Characterisation of a recombinant fragment that contain a carbohydrate recognition domain of the filamentous haemagglutinin. Infect. Immun. 65:1997;3465-3468.
89. Sato Y., Izumiya K., Sato H., Cowell J.L., Manclark C.R. Role of antibody to leukocytosis-promoting factor haemagglutinin and to filamentous haemagglutinin in immunity to pertussis. Infect. Immun. 31:1981;1223-1231.
90. Urisu A., Cowell J.L., Manclark C.R. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect. Immun. 52:1986;695-701.
91. Menozzi F.D., Boucher P.E., Riveau G., Gantiez C., Locht C. Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect. Immun. 62:1994;4261-4269.
92. Hannah J.H., Menozzi F.D., Renauld G., Locht C., Brennan M.J. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62:1994;5010-5019.
93. Relman D., Tuomanen E., Falkow S., Golenbock D.T., Saukkonen K., Wright S.D. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell. 61:1990;1375-1382.
94. Hynes R.O. Integrins: versatility, modulation, and signalling. Cell. 69:1992;11-25.
95. Ruoslahti E., Pierschbacher M.D. Arg-Gly-Asp: a versatile cell recognition signal. Cell. 238:1986;491-497.
96. Ishibashi Y., Claus S., Relman D.A. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1994;1225-1233.
97. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1042.
98. Hazenbos W.L., van den Berg B.M., van Furth R. Very late antigen-5 and complement receptor type 3 cooperatively mediate the interaction between Bordetella pertussis and human monocytes. J. Immunol. 151:1993;6274-6282.
99. Hazenbos W.L., Geuijen C.A., van den Berg B.M., Mooi F.R., van Furth R. Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD. J. Infect. Dis. 171:1995;924-929.
100. Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1991;1143-1149.
101. Steed L.L., Setareh M., Friedman R.L. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J. Leukoc. Biol. 50:1991;321-330.
102. Berggård K., Johnsson E., Mooi F.R., Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous haemagglutinin. Infect. Immun. 65:1997;3638-3643.
103. Locht C., Geoffroy M.C., Renauld G. Common accessory genes for the Bordetella pertussis filamentous hemagglutinin and fimbriae share sequence similarities with the papC and papD gene families. EMBO J. 11:1992;3175-3183.
104. Willems R.J., van der Heide H.G., Mooi F.R. Characterization of a Bordetella pertussis fimbrial gene cluster which is located directly downstream of the filamentous haemagglutinin gene. Mol. Microbiol. 6:1992;2661-2671.
105. Jacob-Dubuisson F., Buisine C., Mielcarek N., Clement E., Menozzi F.D., Locht C. Amino-terminal maturation of the Bordetella pertussis filamentous hemagglutinin. Mol. Microbiol. 19:1996;65-78.
106. Jacob-Dubuisson F., Buisine C., Mielcarek N., Clement E., Menozzi F.D., Locht C. Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous haemagglutinin. J. Biol. Chem. 274:1999;37731-37735.
107. Willems R.J., Geuijen C., van der Heide H.G., Renauld G., Bertin P., van den Akker W.M., Locht C., Mooi F.R. Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA. Mol. Microbiol. 11:1994;337-347.
108. Guédin S., Willery E., Tommassen J., Fort E., Drobecq H., Locht C., Jacob-Dubuisson F. Novel topological features of FhaC, the outer membrane transporter involved in the secretion of the Bordetella pertussis filamentous haemagglutinin. J. Biol. Chem. 275:2000;30202-30210.
109. Barenkamp S.J., St Geme J.W. III. Genes encoding high molecular weight adhesion proteins of non-typeable Haemophilus influenzae are part of gene clusters. Infect. Immun. 62:1994;3320-3328.
110. Lambert-Buisine C., Willery E., Locht C., Jacob-Dubuisson F. N-terminal characterization of the Bordetella pertussis filamentous haemagglutinin. Mol. Microbiol. 28:1998;1283-1293.
111. Smith A.M., Yan H., Groves N., Dalla Pozza T., Walker M.J. Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli. FEMS Microbiol. Lett. 191:2000;177-182.
112. Renauld-Mongenie G., Mielcarek N., Cornette J., Schacht A.-M., Capron A., Riveau G., Locht C. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunisation with recombinant Bordetella pertussis. Proc. Natl. Acad. Sci. USA. 93:1996;7944-7949.
113. Steven A.C., Bisher M.E., Trus B.L., Thomas D., Zhang J.M., Cowell J.L. Helical structure of Bordetella pertussis fimbriae. J. Bacteriol. 167:1986;968-974.
114. Heck D.V., Trus B.L., Steven A.C. Three-dimensional structure of Bordetella pertussis fimbriae. J. Struct. Biol. 116:1996;264-269.
115. Geuijen C.A., Willems R.J., Bongaerts M., Top J., Gielen H., Mooi F.R. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect. Immun. 65:1997;4222-4228.
116. Mooi F.R., ter Avest A., van der Heide H.G. Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunit. FEMS Microbiol. Lett. 54:1990;327-331.
117. Livey I., Duggleby C.J., Robinson A. Cloning and nucleotide sequence analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Mol. Microbiol. 1:1987;203-209.
118. Pedroni P., Riboli B., de Ferra F., Grandi G., Toma S., Arico B., Rappuoli R. Cloning of a novel pilin-like gene from Bordetella pertussis: homology to the fim2 gene. Mol. Microbiol. 2:1988;539-543.
119. Riboli B., Pedroni P., Cuzzoni A., Grandi G., de Ferra F. Expression of Bordetella pertussis fimbrial (fim) genes in Bordetella bronchiseptica: fimX is expressed at a low level and vir-regulated. Microb. Pathogen. 10:1991;393-403.
120. Boschwitz J.S., van der Heide H.G.J., Mooi F.R., Relman D.A. Bordetella bronchiseptica expresses the fimbrial structural subunit gene fimA. J. Bacteriol. 179:1997;7882-7885.
121. Geuijen C.A., Willems R.J., Mooi F.R. The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars. Infect. Immun. 64:1996;2657-2665.
122. Geuijen C.A., Willems R.J., Hoogerhout P., Puijk W.C., Meloen R.H., Mooi F.R. Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis. Infect. Immun. 66:1998;2256-2263.
123. Pearce A.M., Seabrook R.N., Irons L.I., Ashworth L.A., Atkinson T., Robinson A. Localization of antigenic domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae. Microbiology. 140:1994;205-211.
124. Williamson P., Matthews R. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol. Med. Microbiol. 13:1996;169-178.
125. Allen B.L., Gerlach G.F., Clegg S. Nucleotide sequence and functions of mrk determinants necessary for expression of type 3 fimbriae in Klebsiella pneumoniae. J. Bacteriol. 173:1991;916-920.
126. van Ham S.M., van Alphen L., Mooi F.R., van Putten J.P.M. The fimbrial gene cluster of Haemophilus influenzae type b. Mol. Microbiol. 13:1994;673-684.
127. Willems R.J., Geuijen C., van der Heide H.J.G., Matheson M., Robinson A., Versluis L.F., Ebberink R., Theelen J., Mooi F.R. Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene. Mol. Microbiol. 9:1993;623-634.
128. Gerlach G.F., Clegg S., Allen B.L. Identification and characterisation of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J. Bacteriol. 171:1989;1262-1270.
129. Klemm P., Christiansen G. Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 201:1987;439-445.
130. Hazenbos W.L., van den Berg B.M., Geuijen C.W., Mooi F.R., van Furth R. Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J. Immunol. 155:1995;3972-3978.
131. Menozzi F.D., Gantiez C., Locht C. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol. Lett. 62:1991;59-64.
132. Ashworth L.A.E., Fitzgeorge R.B., Irons L.I., Morgan C.P., Robinson A. Rabbit nasopharyngeal colonisation by Bordetella pertussis: the effects of immunisation on clearance and on serum and nasal antibody levels. J. Hyg. 88:1982;475-479.
133. Willems R., Paul A., van der Heide H.G.J., ter Avest A.R., Mooi F.R. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J. 9:1990;2803-2809.
134. Leininger E., Roberts M., Kenimer J.G., Charles I.G., Fairweather N., Novotny P., Brennan M.J. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA. 88:1991;345-349.
135. Makoff A.J., Oxer M.D., Ballantine S.P., Fairweather N.F., Charles I.G. Protective surface antigen P69 of Bordetella pertussis: its characterization and very high level expression in Escherichia coli. BioTechnology. 8:1990;1030-1033.
136. Li L.J., Dougan G., Novotny P., Charles I.G. P.70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli. Mol. Microbiol. 5:1991;409-417.
137. Montaraz J.A., Novotny P., Ivanyi J. Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect. Immun. 47:1985;744-751.
138. Emsley P., Charles I.G., Fairweather N.F., Isaacs N.W. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature. 381:1996;90-92.
139. Charles I.G., Dougan G., Pickard D., Chatfield S., Smith M., Novotny P., Morrissey P., Fairweather N.F. Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc. Natl. Acad. Sci. USA. 86:1988;3554-3558.
140. Charles I.G., Li J.L., Roberts M., Beesley K., Romanos M., Pickard D.J., Francis M., Campbell D., Dougan G., Brennan M.J., et al. Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur. J. Immunol. 21:1991;1147-1153.
141. Charles I., Fairweather N., Pickard D., Beesley J., Anderson R., Dougan G., Roberts M. Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain. Microbiology. 140:1994;3301-3308.
142. Li J., Fairweather N.F., Novotny P., Dougan G., Charles I.G. Cloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 pertactin from Bordetella bronchiseptica. J. Gen. Microbiol. 138:1992;1697-1705.
143. Hynes R.O. Integrins: a family of cell surface receptors. Cell. 48:1987;549-554.
144. Leininger E., Ewanowich C.A., Bhargava A., Peppler M.S., Kenimer J.G., Brennan M.J. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect. Immun. 60:1992;2380-2385.
145. Everest P., Li J., Douce G., Charles I., De Azavedo J., Chatfield S., Dougan G., Roberts M. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Microbiology. 142:1996;3261-3268.
146. Novotny P., Chubb A.P., Cownley K., Charles I.G. Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: a novel formulation for an acellular pertussis vaccine. J. Infect. Dis. 164:1991;114-122.
147. Roberts M., Cropley I., Chatfield S., Dougan G. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine. 11:1993;866-872.
148. Romanos M.A., Clare J.J., Beesley K.M., Rayment F.B., Ballantine S.P., Makoff A.J., Dougan G., Fairweather N.F., Charles I.G. Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties. Vaccine. 9:1991;901-906.
149. Shahin R.D., Brennan M.J., Li Z.M., Meade B.D., Manclark C.R. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J. Exp. Med. 171:1990;63-73.
150. Strugnell R., Dougan G., Chatfield S., Charles I., Fairweather N., Tite J., Li J.L., Beesley J., Roberts M. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 60:1992;3994-4002.
151. Greco, D., Salmaso, S., Mastrantonio, P., Giuliano, M., Tozzi, A.E., Anemona, A., Ciofi Degli Atti, M.L., Giammanco, A., Panei, P., Blackwelder, W.C., Klein, D.L., Wassilak, S.G. andthe Progetto Pertosse Working Group (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis, New Engl. J. Med. 334, 341-348.
152. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. New Engl. J. Med. 334:1996;349-355.
153. Tamura M., Nogimori K., Murai S., Yajima M., Ito K., Katada T., Ui M., Ishii S. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry. 21:1982;5516-5522.
154. Katada T., Tamura M., Ui M. The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalysing ADP-ribosylation of a membrane protein. Arch. Biochem. Biophys. 224:1983;290-298.
155. Locht C., Keith J.M. Pertussis toxin gene: nucleotide sequence and genetic organisation. Science. 232:1986;1258-1263.
156. Nicosia A., Perugini M., Franzini C., Casagli M.C., Borri M.G., Antoni G., Almoni M., Neri P., Ratti G., Rappuoli R. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc. Natl. Acad. Sci. USA. 83:1986;4631-4635.
157. Nicosia A., Bartoloni A., Perugini M., Rappuoli R. Expression and immunological properties of the five subunits of pertussis toxin. Infect. Immun. 55:1987;963-967.
158. Burnette N., Mar V.L., Cieplak W., Kaljot K.T., Marchitto K.S., Sachdev R.K., Locht C., Keith J.M. Direct expression of B. pertussis toxin subunits to high levels in E. coli. BioTechnology. 6:1988;699-706.
159. Arico B., Gross R., Smida J., Rappuoli R. Evolutionary relationships in the genus Bordetella. Mol. Microbiol. 1:1987;301-308.
160. Runeberg-Nyman K., Engstrom O., Lofdahl S., Ylostalo S., Sarvas M. Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis. Microb. Pathogen. 3:1987;461-468.
161. Saris P., Taira S., Airaksinen U., Palva A., Sarvas M., Palva I., Runeberg-Nyman K. Production and secretion of pertussis toxin subunits in Bacillus subtilis. FEMS Microbiol. Lett. 68:1990;143-148.
162. Dalla Pozza T., Yan H., Walker M.J. Expression of a synthetic pertussis toxin operon in Escherichia coli. Vaccine. 15:1997;968-975.
163. Dalla Pozza T., Yan H., Meek D., Guzman C.A., Walker M.J. Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits. Vaccine. 16:1998;522-529.
164. Nascimento I.P., Dias W.O., Mazzantini R.P., Miyaji E.N., Gamberini M., Quintilio W., Gebara V.C., Cardoso D.F., Ho P.L., Raw I., Winter N., Gicquel B., Rappuoli R., Leite L.C.C. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68:2000;4877-4883.
165. Lee C.K., Roberts A., Perrin S. Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. Infect. Immun. 57:1989;1413-1418.
166. Nencioni L., Pizza M., Bugnoli M., deMagistris T., diTommaso A., Giovannoni F., Manetti R., Marsili I., Matteucci G., Nucci D., et al. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect. Immun. 58:1990;1308-1315.
167. Pizza M., Covacci A., Bartoloni A., Perugini M., Nencioni L., De M.M., Villa L., Nucci D., Manetti R., Bugnoli M. Mutants of pertussis toxin suitable for vaccine development. Science. 246:1989;497-500.
168. Zealey G.R., Loosmore S.M., Yacoob R.K., Cockle S.A., Herbert A.B., Miller L.D., Mackay N.J., Klein M.H. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin. Appl. Environ.
169. Suarez A., Staendner L.H., Rhode M., Piatti G., Timmis K.N., Guzman C.A. Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter. Appl. Environ. Microbiol. 63:1997;122-127.
170. Walker M.J., Rohde M., Wehland J., Timmis K.N. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica. Infect. Immun. 59:1991;4238-4248.
171. Smith A.M., Walker M.J. Transfer of a pertussis toxin expression locus to isogenic bvg-positive and bvg-negative strains of Bordetella bronchiseptica using an in vivo technique. Microb. Pathogen. 20:1996;263-273.
172. Weiss A.A., Johnson F.D., Burns D.L. Molecular characterization of an operon required for pertussis toxin secretion. Proc. Natl. Acad. Sci. USA. 90:1993;2970-2974.
173. Farizo K.M., Cafarella T.G., Burns D.L. Evidence for a ninth gene, ptlI in the locus encoding the pertussis toxin secretion system of Bordetella pertussis and formation of a PtlI-PtlF complex. J. Biol. Chem. 271:1996;31643-31649.
174. Johnson F.D., Burns D.L. Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J. Bacteriol. 176:1994;5350-5356.
175. Kotob S.I., Hausman S.Z., Burns D.L. Localization of the promoter for the ptl genes of Bordetella pertussis, which encode proteins essential for secretion of pertussis toxin. Infect. Immun. 63:1995;3227-3230.
176. Baker S.M., Masi A., Liu D.F., Novitsky B.K., Deich R.A. Pertussis toxin export genes are regulated by the ptx promoter and may be required for efficient translation of ptx mRNA in Bordetella pertussis. Infect. Immun. 63:1995;3920-3926.
177. Hausman S.Z., Cherry J.D., Heininger U., Wirsing von Konig C.H., Burns D.L. Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infect. Immun. 64:1996;4020-4026.
178. Welch R.A. Pore-forming cytolysins of Gram-negative bacteria. Mol. Microbiol. 5:1991;521-528.
179. Khelef N., Sakamoto H., Guiso N. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb. Pathogen. 12:1992;227-235.
180. Glaser P., Ladant D., Sezer O., Pichot F., Ullmann A., Danchin A. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol. Microbiol. 2:1988;19-30.
181. Gentile F., Knipling L.G., Sackett D.L., Wolff J. Invasive adenylyl cyclase of Bordetella pertussis. Physical, catalytic, and toxic properties. J. Biol. Chem. 265:1990;10686-10692.
182. Leusch M.S., Paulaitis S., Friedman R.L. Adenylate cyclase toxin of Bordetella pertussis: production, purification, and partial characterization. Infect. Immun. 58:1990;3621-3626.
183. Rogel A., Schultz J.E., Brownlie R.M., Coote J.G., Parton R., Hanski E. Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme. EMBO J. 8:1989;2755-2760.
184. Ladant D., Michelson S., Sarfati R., Gilles A.M., Predeleanu R., Barzu O. Characterization of the calmodulin-binding and of the catalytic domains of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 264:1989;4015-4020.
185. Heveker N., Ladant D. Characterisation of mutant Bordetella pertussis adenylate cyclase toxins with reduced affinity for calmodulin. Eur. J. Biochem. 243:1997;643-649.
186. Confer D.L., Eaton J.W. Pathogen-host jujitsu: phagocyte impotence caused by internalized bacterial adenylate cyclase. Trans. Assoc. Am. Phys. 95:1982;1-7.
187. Greenlee D.V., Andreasen T.J., Storm D.R. Calcium-independent stimulation of Bordetella pertussis adenylate cyclase toxin by calmodulin. Biochemistry. 21:1982;2759-2764.
188. Sakamoto H., Bellalou J., Sebo P., Ladant D. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities. J. Biol. Chem. 267:1992;13598-13602.
189. Boehm D.F., Welch R.A., Snyder I.S. Domains of Escherichia coli haemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58:1990;1959-1966.
190. Ludwig A., Jarchau T., Benz R., Goebel W. Mutations affecting activity and transport of haemolysin in Escherichia coli. Mol. Gen. Genet. 214:1988;553-561.
191. Rose T., Sebo P., Bellalou J., Ladant D. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J. Biol. Chem. 270:1995;26370-26376.
192. Goyard S., Sebo P., D'Andria O., Ladant D., Ullmann A. Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278:1993;326-333.
193. Glaser P., Sakamoto H., Bellalou J., Ullmann A., Danchin A. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:1988;3997-4004.
194. Barry E.M., Weiss A.A., Ehrmann I.E., Gray M.C., Hewlett E.L., Goodwin M.S. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J. Bacteriol. 173:1991;720-726.
195. Hackett M., Guo L., Shabanowitz J., Hunt D.F., Hewlett E.L. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science. 266:1994;433-435.
196. Gordon V.M., Young W.J., Lechler S.M., Gray M.C., Leppla S.H., Hewlett E.L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 264:1989;14792-14796.
197. Rogel A., Hanski E. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J. Biol. Chem. 267:1992;22599-22605.
198. Arciniega J.L., Hewlett E.L., Johnson F.D., Deforest A., Wassilak S.G., Onorato I.M., Manclark C.R., Burns D.L. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J. Infect. Dis. 163:1991;135-142.
199. Guiso N., Szatanik M., Rocancourt M. Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization. Microb. Pathogen. 11:1991;423-431.
200. Hewlett E.L., Manclark C.R., Wolff J. Adenylyl cyclase in Bordetella pertussis vaccines. J. Infect. Dis. 136:1977;5216-5219.
201. Guiso N., Rocancourt M., Szatanik M., Alonso J.M. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Microb. Pathogen. 7:1989;373-380.
202. Novotny P., Chubb A.P., Cownley K., Montaraz J.A. Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica. Infect. Immun. 50:1985;199-206.
203. Friedman R.L., Nordensson K., Wilson L., Akporiaye E.T., Yocum D.E. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:1992;4578-4585.
204. Masure H.R. Modulation of adenylate cyclase toxin production as Bordetella pertussis enters human macrophages. Proc. Natl. Acad. Sci. USA. 89:1992;6521-6525.
205. Karimova G., Fayolle C., Gmira S., Ullmann A., Leclerc C., Ladant D. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implications for the in vivo delivery of CD8(+) T cell epitopes into antigen presenting cells. Proc. Natl. Acad. Sci. USA. 95:1998;12532-12537.
206. Dadaglio G., Moukrim Z., Lo-Man R., Sheshko V., Sebo P., Leclerc C. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Infect. Immun. 68:2000;3867-3872.
207. Gueirard P., Druilhe A., Pretolani M., Guiso N. Role of adenylate cyclase toxin/haemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect. Immun. 66:1998;1718-1725.
208. Khelef N., Zychlinsky A., Guiso N. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect. Immun. 61:1993;4064-4071.
209. Khelef N., Guiso N. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol. Lett. 134:1995;27-32.
210. Bordet J., Gengou O. L'endotoxine coquelucheuse. Ann. Inst. Pasteur (Paris). 23:1909;415-419.
211. Iida T., Okonogi T. Lienotoxicity of Bordetella pertussis in mice. J. Med. Microbiol. 4:1971;51-61.
212. Livey I., Wardlaw A.C. Production and properties of Bordetella pertussis heat-labile toxin. J. Med. Microbiol. 17:1984;91-103.
213. Endoh M., Amitani M., Nakase Y. Effect of purified heat-labile toxin of Bordetella bronchiseptica on the peripheral blood vessels in guinea pigs or suckling mice. Microbiol. Immunol. 30:1986;1327-1330.
214. Endoh M., Nagai M., Ueda T., Yoshida Y., Nakase Y. Cytopathic effect of heat-labile toxin of Bordetella parapertussis on aortic smooth muscle cells from pigs or guinea pigs. Microbiol. Immun. 32:1988;423-428.
215. Gentry-Weeks C.R., Keith J.M., Thompson J. Toxicity of Bordetella avium beta-cystathionase toward MC3t3-El osteogenic cells. J. Biol. Chem. 268:1988;7298-7314.
216. Cowell J.L., Hewlett E.L., Manclark C.R. Intracellular localisation of the dermonecrotic toxin of Bordetella pertussis. Infect. Immun. 25:1979;896-901.
217. Horiguchi Y., Nakai T., Kume K. Simplified procedure for purification of Bordetella bronchiseptica dermonecrotic toxin. FEMS Microbiol. Lett. 66:1990;39-43.
218. Zhang Y.L., Sekura R.D. Purification and characterization of the heat-labile toxin of Bordetella pertussis. Infect. Immun. 59:1991;3754-3759.
219. Walker K.E., Weiss A.A. Characterization of the dermonecrotic toxin in members of the Genus Bordetella. Infect. Immun. 62:1994;3817-3828.
220. Falbo V., Pace T., Picci L., Pizzi E., Caprioli A. Isolation and nucleotide sequence of the gene encoding cytotoxin necrotising factor I in Escherichia coli. Infect. Immun. 61:1993;4909-4916.
221. Hoshijima M., Kondo J., Kikuchi A., Yamamoto K., Takai Y. Purification and characterisation from bovine membranes of a GTP-binding protein with a Mr of 21 000, ADP-ribosylated by an ADP-ribosyltransferase contaminated in botulinum toxin type C1-identification as the rhoA gene product. Mol. Brain Res. 7:1990;9-16.
222. Oswald E., Sugai M., Labigne A., Wu H.C., Fiorentini C., Boquet P., O'Brien A.D. Cytotoxic necrotising factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibres. Proc. Natl. Acad. Sci. USA. 91:1994;3814-3818.
223. Rozengurt E., Higgins T., Chater N., Lax A.J., Staddon J.M. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. USA. 87:1990;123-127.
224. Schmidt G., Goehring U.M., Schirmer J., Lerm M., Aktories K. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases. J. Biol. Chem. 275:1999;31875-31881.
225. Cookson B.T., Cho H.L., Herwaldt L.A., Goldman W.E. Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis. Infect. Immun. 57:1989;2223-2229.
226. Cookson, B.T. and Goldman, W.E. (1987) Tracheal cytotoxin: a conserved virulence determinant of all Bordetella species. J. Cell. Biochem. (Suppl.) 11B, 124 (abstr. H208).
227. Sinha R.K., Rosenthal R.S. Release of soluble peptidoglycan from growing gonococci: demonstration of anhydro-muramyl-containing fragments. Infect. Immun. 29:1980;914-925.
228. Luker K.E., Tyler A.N., Marshall G.R., Goldman W.E. Tracheal cytotoxin structural requirements for respiratory epithelial damage in pertussis. Mol. Microbiol. 16:1995;733-743.
229. Heiss L.N., Moser S.A., Unanue E.R., Goldman W.E. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect. Immun. 61:1993;3123-3128.
230. Heiss L.N., Lancaster J.J., Corbett J.A., Goldman W.E. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. USA. 91:1994;267-270.
231. Cundell D.R., Kanthakumar K., Taylor G.W., Goldman W.E., Flak T., Cole P.J., Wilson R. Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect. Immun. 62:1994;639-643.
232. Amano K., Fukushi K., Watanabe M. Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J. Gen. Microbiol. 136:1990;481-487.
233. Watanabe M., Takimoto H., Kumazawa Y., Amano K. Biological properties of lipopolysaccharides from Bordetella species. J. Gen. Microbiol. 136:1990;489-493.
234. Chaby, R. and Caroff, M. (1988) in: Pathogenesis and Immunity in Pertussis (Wardlaw, A.C. and Parton, R., Eds.), pp. p247-271. Wiley, New York.
235. Peppler M.S. Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect. Immun. 43:1984;224-232.
236. Caroff M., Chaby R., Karibian D., Perry J., Deprun C., Szabo L. Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J. Bacteriol. 172:1990;1121-1128.
237. van den Akker W.M.R. Lipopolysaccharide expression within the genus Bordetella - influence of temperature and phase variation. Microbiology. 144:1998;1527-1535.
238. Porter J.F., Connor K., van der Zee A., Reubsaet F., Ibsen P., Heron I., Chaby R., Le Blay K., Donachie W. Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity. FEMS Microbiol. Lett. 132:1995;195-201.
239. van der Zee A., Groenendijk H., Peeters M., Mooi F.R. The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int. J. Syst. Bacteriol. 46:1996;640-647.
240. Di Fabio J.L., Caroff M., Karibian D., Richards J.C., Perry M.B. Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis. FEMS Microbiol. Lett. 76:1992;275-281.
241. Banemann A., Deppisch H., Gross R. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect. Immun. 66:1998;5607-5612.
242. Leblay K., Gueirard P., Guiso N., Chaby R. Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica. Microbiology. 143:1997;1433-1441.
243. Allen A., Maskell D. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol. Microbiol. 19:1996;37-52.
244. Finn T.M., Shahin R., Mekalanos J.J. Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis. Infect. Immun. 59:1991;3273-3279.
245. Finn T.M., Stevens L.A. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16:1995;625-634.
246. Fernandez R.C., Weiss A.A. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:1994;4727-4738.
247. Rambow A.A., Fernandez R.C., Weiss A.A. Characterization of brkA expression in Bordetella bronchiseptica. Infect. Immun. 66:1998;3978-3980.
248. Fernandez R.C., Weiss A.A. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 163:1998;57-63.
249. Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:1991;4715-4719.
250. Ewanowich C.A., Melton A.R., Weiss A.A., Sherburne R.K., Peppler M.S. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect. Immun. 57:1989;2698-2704.
251. Petersen J.W., Ibsen P.H., Haslov K., Heron I. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect. Immun. 60:1992;4563-4570.
252. Redhead K., Watkins J., Barnard A., Mills K.H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:1993;3190-3198.
253. Mahon B.P., Ryan M.S., Griffin F., Mills K.H.G. Interleukin-12 is produced by live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:1996;5295-5301.
254. Mills K.H.G., Ryan M., Ryan E., Mahon B.P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:1998;594-602.
255. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H.G. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology. 87:1996;372-380.
256. Ausiello C.M., Urbani F., La Sala A., Lande R., Piscitelli A., Cassone A. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev. Biol. Stand. 89:1997;315-320.
257. Zepp F., Knuf M., Habermehl P., Schmitt H.J., Rebsch C., Schmidtke P., Clemens R., Slaoui M. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:1996;4078-4084.
258. Zepp F., Knuf M., Habermehl P., Schmitt H.J., Meyer C., Clemens R., Slaoui M. Cell-mediated immunity after pertussis vaccination and after natural infection. Dev. Biol. Stand. 89:1997;307-314.
259. de Melker H.E., Conyn-van Spaendonck M.A.E., Rümke H.C., van Wijngaarden J.K., Mooi F.R., Schellekens J.F.P. Pertussis in the Netherlands: an outbreak despite high levels of immunisation with whole-cell vaccine. Emerg. Infect. Dis. 3:1997;175-178.
260. Mooi F.R., van Oirschot H., Heuvelman K., van der Heide H.G.J., Gaastra W., Willems R.J.L. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:1998;670-675.
261. Peppoloni S., Pizza M., de Magistris M.T., Bartoloni A., Rappuoli R. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin. Physiol. Chem. Phys. Med. NMR. 27:1995;355-361.
262. Sanger Centre Website (2000) http://www.sanger.ac.uk/Projects/B_pertussis/ [19 March 2000, last date accessed].